More than 200 biotech executives, investors and scientists have signed an open letter condemning a Texas judge's decision to overturn the FDA approval of mifepristone, an abortion pill that's been widely used for more than two decades.
More than 200 biotech executives, investors and scientists have signed an open letter condemning a Texas judge's decision to overturn the FDA approval of mifepristone, an abortion pill that's been widely used for more than two decades.
